These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 18509186)

  • 1. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: consensus of an Italian expert panel.
    Pession A; Masetti R; Gaidano G; Tosi P; Rosti G; Aglietta M; Specchia G; Porta F; Pane F
    Adv Ther; 2011 Aug; 28(8):684-97. PubMed ID: 21779956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management.
    Abu-Alfa AK; Younes A
    Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of tumor lysis syndrome.
    Rampello E; Fricia T; Malaguarnera M
    Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor lysis syndrome in elderly.
    Pumo V; Sciacca D; Malaguarnera M
    Crit Rev Oncol Hematol; 2007 Oct; 64(1):31-42. PubMed ID: 17658268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tumor lysis syndrome].
    Hagino T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):984-8. PubMed ID: 20567098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rasburicase versus allopurinol in the treatment of hyperuricaemia in tumour lysis syndrome].
    Tatay VS; Castilla JD; Ponce JM; Hurtado JM; Cantero E; Abril ML
    An Pediatr (Barc); 2010 Feb; 72(2):103-10. PubMed ID: 20022572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
    Cheson BD
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor lysis syndrome and clinical guidelines].
    Ishizawa K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):135-40. PubMed ID: 24743190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
    Kennedy LD; Ajiboye VO
    J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
    Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
    J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
    [No Abstract]   [Full Text] [Related]  

  • 16. Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
    Bessmertny O; Robitaille LM; Cairo MS
    Curr Pharm Des; 2005; 11(32):4177-85. PubMed ID: 16375739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of tumor lysis syndrome with the highest known uric acid level.
    Ozkan G; Ulusoy S; Sönmez M; Kaynar K; Karagülle M
    Ren Fail; 2010; 32(7):895-8. PubMed ID: 20662707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
    Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
    Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.